FORBES-TATE lobbying for NATIONAL ASSOCIATION OF PROTON THERAPY

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 17, 2025

Bills named in this filing 2

S 1031
ROCR Value Based Program Act
HR 2120
ROCR Value Based Program Act

Lobbying activity 4

Medicare/Medicaid

Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.

Health Issues

Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.

Budget/Appropriations

Issues related to continued access to and provider reimbursement for proton beam therapy; issues related to the Fiscal Year 2026 Labor-HHS appropriations process.

Veterans

Issues pertaining to veterans' access to proton therapy.